Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-09-17
2011-11-15
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S235200, C514S249000, C514S253090, C514S254090, C514S323000, C514S397000, C514S418000, C544S058100, C544S144000, C544S354000, C544S364000, C544S373000, C546S201000, C548S312100, C548S485000, C548S486000
Reexamination Certificate
active
08058269
ABSTRACT:
There is provided compounds of the formulawherein R6, V, W, X, Y, Q and n are as described. The compounds exhibit activity as anticancer agents.
REFERENCES:
patent: 3441570 (1969-04-01), Meyer
patent: 0947511 (1999-10-01), None
patent: WO 00/15657 (2000-03-01), None
patent: WO 2006/136606 (2006-12-01), None
Hellmann et al. Chemical Abstracts vol. 49, abstract No. 8230 (1955) Abstract for Chemische Berichte vol. 86, pp. 1346-1361 (1953).
Alarcon-Vargas, D et al,Carcinogenesis, 23(4):541-547 (2002) XP002481521.
Hellmann, H et al, Cheische Berichte, ISSN.009-2440, vol. 86, 1346-1361 (1953) XP002481520.
Shigemori, H. et al., Database accession No. 2003:27172, 59(1), Heterocycles, 275-281, Chemical abstracts Service, Columbus, OH XP002481522.
Chen Li
Yang Song
Zhang Jing
Zhang Zhuming
Bernhardt Emily
Hoffman-La Roche Inc.
Johnston George W.
Rocha-Tramaloni Patricia S.
LandOfFree
Oxindole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxindole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxindole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4301290